NO | 코드 | 원발부위 | 고양시 | 근접지역 | 기타 | 서울 | 2017년 | 2016년 환자수 |
전년대비 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
일산구 | 덕양구 | 소계 | 김포시 | 파주시 | 경기도 | 소계 | 환자수 | 구성비 | 증감수 | 증감율 | ||||||
1 | C00 | cancer, lip | 1 | - | 1 | - | - | - | - | - | - | 1 | 0.1% | 1 | - | 0.0% |
2 | C01 | cancer, base of tongue | 3 | - | 3 | - | - | 1 | 1 | - | 1 | 5 | 0.3% | 1 | 4 | 400% |
3 | C02 | cancer, other and unspecified parts of tongue | - | - | - | 1 | - | - | 1 | - | - | 1 | 0.1% | 5 | -4 | -80.0% |
4 | C03 | cancer, gum | - | - | - | - | - | - | - | - | - | - | 0.0% | 4 | -4 | -100% |
5 | C04 | cancer, floor of mouth | - | - | - | - | - | - | - | - | - | - | 0.0% | - | - | |
6 | C05 | cancer, palate | - | - | - | - | - | - | - | - | - | - | 0.0% | 3 | -3 | -100% |
7 | C06 | cancer, other and unspecified parts of mouth | 1 | - | 1 | - | - | - | - | - | 1 | 2 | 0.1% | 2 | - | 0.0% |
8 | C07 | cancer, parotid gland | 2 | - | 2 | - | 1 | - | 1 | - | 1 | 4 | 0.2% | 3 | 1 | 33.3% |
9 | C08 | cancer, other and unspecified major salivary gland | 1 | - | 1 | - | - | - | - | - | 1 | 2 | 0.1% | 2 | - | 0.0% |
10 | C09 | cancer, tonsil | 3 | 1 | 4 | 1 | 2 | - | 3 | - | - | 7 | 0.4% | 1 | 6 | 600% |
11 | C10 | cancer, oropharynx | 1 | 1 | 2 | - | - | - | - | - | - | 2 | 0.1% | - | 2 | |
12 | C11 | cancer, nasopharynx | 2 | - | 2 | - | 1 | - | 1 | 1 | - | 4 | 0.2% | 2 | 2 | 100% |
13 | C12 | cancer, pyriform sinus | 1 | - | 1 | - | - | - | - | 1 | 1 | 3 | 0.2% | - | 3 | |
14 | C13 | cancer, hypopharynx | 2 | - | 2 | - | - | - | - | - | - | 2 | 0.1% | 6 | -4 | -66.7% |
15 | C14 | cancer, other and ill-defined sites in the lip, oral cavity and pharynx |
- | - | - | - | - | - | - | - | - | - | 0.0% | 1 | -1 | -100% |
16 | C15 | cancer, esophagus | 5 | 5 | 10 | 1 | 4 | - | 5 | 3 | - | 18 | 1.0% | 19 | -1 | -5.3% |
17 | C16 | cancer, stomach | 55 | 36 | 91 | 10 | 36 | 6 | 52 | 12 | 19 | 174 | 9.4% | 161 | 13 | 8.1% |
18 | C17 | cancer, small bowel(small intestine) | 3 | 4 | 7 | - | 2 | 1 | 3 | - | - | 10 | 0.5% | 11 | -1 | -9.1% |
19 | C18~C20 | cancer, colon and rectum | 75 | 66 | 141 | 9 | 55 | 17 | 81 | 25 | 19 | 266 | 14.4% | 255 | 11 | 4.3% |
20 | C21 | cancer, anus and anal canal | 1 | - | 1 | - | - | - | - | - | - | 1 | 0.1% | - | 1 | |
21 | C22 | cancer, liver and intrahepatic bile ducts | 45 | 30 | 75 | 5 | 26 | 9 | 40 | 13 | 13 | 141 | 7.6% | 143 | -2 | -1.4% |
22 | C23 | cancer, GB(gallbladder) | 9 | 5 | 14 | 2 | 4 | 4 | 10 | 3 | 5 | 32 | 1.7% | 29 | 3 | 10.3% |
23 | C24 | cancer, other and unspecified parts of biliary tract | 11 | 9 | 20 | 2 | 9 | 3 | 14 | 4 | 5 | 43 | 2.3% | 40 | 3 | 7.5% |
24 | C25 | cancer, pancreas | 24 | 19 | 43 | 4 | 20 | 3 | 27 | 14 | 11 | 95 | 5.1% | 83 | 12 | 14.5% |
25 | C26 | cancer, other and ill-defined digestive organs | - | - | - | - | - | - | - | - | - | - | 0.0% | - | - | |
26 | C30 | cancer, nasal cavity and middle ear | - | 1 | 1 | - | - | - | - | - | - | 1 | 0.1% | 1 | - | 0.0% |
27 | C31 | cancer, accessory sinuses | - | - | - | - | - | 1 | 1 | - | - | 1 | 0.1% | 2 | -1 | -50.0% |
28 | C32 | cancer, larynx | - | 2 | 2 | 1 | - | - | 1 | - | 1 | 4 | 0.2% | 12 | -8 | -66.7% |
29 | C33 | cancer, trachea | - | - | - | - | 1 | - | 1 | - | - | 1 | 0.1% | 1 | - | 0.0% |
30 | C34 | cancer, bronchus and lung | 97 | 48 | 145 | 14 | 47 | 16 | 77 | 31 | 24 | 277 | 15.0% | 244 | 33 | 13.5% |
31 | C37 | cancer, thymus | 3 | - | 3 | 1 | 3 | - | 4 | 1 | - | 8 | 0.4% | 6 | 2 | 33.3% |
32 | C38 | cancer, heart, mediastinum and pleura | 2 | 2 | 4 | 1 | - | 1 | 2 | - | - | 6 | 0.3% | 5 | 1 | 20.0% |
33 | C40 | cancer, bone and articular cartilage of limbs | - | - | - | - | - | - | - | - | - | - | 0.0% | - | - | |
34 | C41 | cancer, bone and articular cartilage of other and unspecified sites | - | - | - | - | - | - | - | - | - | - | 0.0% | 3 | -3 | -100% |
35 | C42 | Hematopoietic and reticuloendothelial system | 14 | 15 | 29 | 3 | 14 | 2 | 19 | 5 | 7 | 60 | 3.2% | 45 | 15 | 33.3% |
36 | C44 | cancer, other skin | 8 | - | 8 | - | 4 | - | 4 | 3 | 2 | 17 | 0.9% | 25 | -8 | -32.0% |
37 | C47 | cancer, peripheral nerves and autonomic nervous system | 1 | - | 1 | - | - | - | - | - | - | 1 | 0.1% | 1 | - | 0.0% |
38 | C48 | cancer, retroperitoneum and peritoneum | 1 | - | 1 | - | - | - | - | - | - | 1 | 0.1% | 4 | -3 | -75.0% |
39 | C49 | cancer, other connective and soft tissue | 4 | 2 | 6 | - | 1 | - | 1 | - | - | 7 | 0.4% | 9 | -2 | -22.2% |
40 | C50 | cancer, breast | 33 | 27 | 60 | 4 | 24 | 2 | 30 | 8 | 7 | 105 | 5.7% | 100 | 5 | 5.0% |
41 | C51 | cancer, vulva | - | 1 | 1 | - | - | - | - | - | - | 1 | 0.1% | 2 | -1 | -50.0% |
42 | C52 | cancer, vagina | - | - | - | - | 1 | - | 1 | - | - | 1 | 0.1% | 1 | - | 0.0% |
43 | C53 | cancer, cervix uteri | 14 | 8 | 22 | 3 | 12 | 1 | 16 | 7 | 3 | 48 | 2.6% | 44 | 4 | 9.1% |
44 | C54 | cancer ,corpus uteri | 7 | 6 | 13 | 3 | 4 | 2 | 9 | - | 5 | 27 | 1.5% | 9 | 18 | 200% |
45 | C55 | cancer, uterus, part unspecified | - | - | - | - | - | - | - | - | - | - | 0.0% | 1 | -1 | -100% |
46 | C56 | cancer, ovary | 3 | 3 | 6 | - | 3 | 1 | 4 | 3 | 4 | 17 | 0.9% | 23 | -6 | -26.1% |
47 | C57 | cancer, other and unspecified female gential organs | - | 1 | 1 | - | - | - | - | - | - | 1 | 0.1% | 1 | - | 0.0% |
48 | C60 | cancer, penis | - | - | - | - | - | - | - | - | 1 | 1 | 0.1% | 1 | - | 0.0% |
49 | C61 | cancer, prostate | 24 | 13 | 37 | 3 | 22 | 3 | 28 | 5 | 12 | 82 | 4.4% | 65 | 17 | 26.2% |
50 | C62 | cancer, testis | - | - | - | - | - | - | - | - | - | - | 0.0% | 2 | -2 | -100% |
51 | C63 | cancer, other and unspecified male gential organs | - | 1 | 1 | - | - | - | - | - | - | 1 | 0.1% | - | 1 | |
52 | C64 | cancer, kidney | 16 | 8 | 24 | - | 9 | 1 | 10 | 5 | 6 | 45 | 2.4% | 46 | -1 | -2.2% |
53 | C65 | cancer, renal pelvis | 1 | 2 | 3 | - | - | 1 | 1 | 1 | 2 | 7 | 0.4% | 3 | 4 | 133.3% |
54 | C66 | cancer, ureter | 2 | - | 2 | 1 | 2 | 1 | 4 | 1 | 3 | 10 | 0.5% | 5 | 5 | 100% |
55 | C67 | cancer, bladder | 18 | 11 | 29 | 1 | 16 | 3 | 20 | 4 | 10 | 63 | 3.4% | 80 | -17 | -21.3% |
56 | C68 | cancer, other and unspecified urinary organs | - | - | - | - | - | - | - | - | 1 | 1 | 0.1% | 2 | -1 | -50.0% |
57 | C69 | cancer, eye and adnexa | 1 | - | 1 | - | - | - | - | - | - | 1 | 0.1% | - | 1 | |
58 | C70 | cancer, meninges | 2 | 3 | 5 | 1 | - | - | 1 | - | 4 | 10 | 0.5% | 8 | 2 | 25.0% |
59 | C71 | cancer, brain | 9 | 3 | 12 | - | 5 | 2 | 7 | 6 | 2 | 27 | 1.5% | 26 | 1 | 3.8% |
60 | C72 | cancer, spinal cord, cranial nerves, other parts of central nervous system | 1 | 1 | 2 | - | 2 | - | 2 | 1 | 3 | 8 | 0.4% | 2 | 6 | 300% |
61 | C73 | cancer, thyroid gland | 49 | 29 | 78 | 8 | 18 | 3 | 29 | 16 | 8 | 131 | 7.1% | 123 | 8 | 6.5% |
62 | C74 | cancer, adrenal gland | 1 | - | 1 | - | - | - | - | - | - | 1 | 0.1% | 1 | - | 0.0% |
63 | C75 | cancer, other endocrine glands and related structures | 5 | 1 | 6 | 2 | 4 | 1 | 7 | - | 3 | 16 | 0.9% | 10 | 6 | 60.0% |
64 | C76 | cancer, other and ill-defined sites | - | - | - | - | - | - | - | - | - | - | 0.0% | 3 | -3 | -100% |
65 | C77 | Secondary and unspecified malignant neoplasm of lymph nodes | 10 | 2 | 12 | 1 | 8 | 2 | 11 | - | 4 | 27 | 1.5% | 33 | -6 | -18.2% |
66 | C80 | cancer without specification of site | 6 | 8 | 14 | 1 | 1 | 1 | 3 | 1 | 1 | 19 | 1.0% | 26 | -7 | -26.9% |
2017년 환자수 합계 | 577 | 374 | 951 | 83 | 361 | 88 | 532 | 174 | 190 | 1,847 | 100% | 1,747 | 100 | 5.7% | ||
2017년 구성비 | 31.2% | 20.2% | 51.5% | 4.5% | 19.5% | 4.8% | 28.8% | 9.4% | 10.3% | 100% | ||||||
2016년 환자수 합계 | 494 | 375 | 869 | 85 | 342 | 89 | 516 | 169 | 193 | 1,747 | ||||||
2016년 구성비 | 28.3% | 21.5% | 49.7% | 4.9% | 19.6% | 5.1% | 29.5% | 9.7% | 11.0% | 100% | ||||||
전년대비 환자수 증감율 | 16.8% | -0.3% | 9.4% | -2.4% | 5.6% | -1.1% | 3.1% | 3.0% | -1.6% | 5.7% | ||||||
전년대비 구성비 증감율 | 10.2% | -6.0% | 3.6% | -8.2% | -0.5% | -5.9% | -2.4% | -3.1% | -6.4% | 0.0% |